How to Determine Testosterone Levels by Looking at Your Ring Finger
You have sent too many requests causing Linguee to block your computerThe latter is found primarily in prostate tissue. Saw palmetto extract SPE testo enantat kur wie lange you been used extensively in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia BPH. Clinical studies of SPE have been inconclusive — some have shown significant results, and others have not — possibly the result of varying bioactivities of the SPEs used in the studies. SPSE effectively inhibits the enzyme that has been linked to BPH, and the amount of extract required for activity is comparatively low. It can be confirmed from the results of this study that SPSE has bioactivity that testosterone derivative dihydrotestosterone prostate health at a level that is superior to that of many other phytotherapeutic extracts. The bioactivity of SPSE corresponds favorably to that reported for the hexane extract used testosterone derivative dihydrotestosterone a large number of testosterone derivative dihydrotestosterone BPH clinical dihydrotestostefone, as well as to dihydrotestostsrone, the established standard of therapy among prescription drugs.
Anavar, die synthetische Ableitung des anabolen Steroids von Dihydrotestosterone
The latter is found primarily in prostate tissue. Saw palmetto extract SPE has been used extensively in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia BPH. Clinical studies of SPE have been inconclusive — some have shown significant results, and others have not — possibly the result of varying bioactivities of the SPEs used in the studies. SPSE effectively inhibits the enzyme that has been linked to BPH, and the amount of extract required for activity is comparatively low.
It can be confirmed from the results of this study that SPSE has bioactivity that promotes prostate health at a level that is superior to that of many other phytotherapeutic extracts. The bioactivity of SPSE corresponds favorably to that reported for the hexane extract used in a large number of positive BPH clinical trials, as well as to finasteride, the established standard of therapy among prescription drugs.
Future in vitro and clinical trials involving SPEs would be useful for elucidating their comparative differences, as well as appropriate patient selection for their use. The final step in androgen biosynthesis is the irreversible reduction of testosterone to DHT. Distinct biochemical and pharmacological properties, such as pH optimum and Km, 1 — 3 characterize the isoenzymes.
Their differing patterns of distribution are still being elucidated. The type I isoenzyme is expressed primarily in skin, scalp, and follicles, and is the predominant form in oil and sweat glands. Found primarily in prostate tissue, type II is expressed in stroma and basal cells of the prostate; type I is also expressed in epithelial cells of the prostate.
BPH confers its morbidity through potentially bothersome lower urinary tract symptoms. The sole function of the prostate is to secrete fluid containing substances that are essential for reproduction, requiring an extremely high tissue concentration of androgens.
Moreover, elevated DHT levels have been shown to correlate with the pathogenesis and progression of androgen-dependent diseases eg, prostate cancer and BPH.
In the US, dietary supplements for promoting prostate health have gained popularity over the last decade. Currently available treatment options in the field of phytotherapy were recently reviewed by Allkanjari and Vitalone, who found that randomized clinical trials indicated significant efficacy in improving urinary symptoms with mild adverse effects for some phytotherapeutic agents, but that further clinical evidence was needed for others eg, Epilobium spp.
SPE has been extensively utilized for the management of lower urinary tract symptoms secondary to BPH. The numerous SPEs available today feature several different extraction processes, resulting in varying levels of BPH-related bioactivity. SPE is the phytotherapeutic agent that is used most frequently for the treatment of the urological symptoms caused by BPH.
The potency of the extracts, as well as the potencies of two different batches of the same extract, appeared to be very different; qualitative and quantitative differences in the active ingredients may explain these results. The investigators recommended that the extract product of each company be tested to evaluate bioactivity and clinical efficacy.
In a more recent study, Scaglione et al compared the activity of different SPEs that are widely available on the world market. The investigators concluded that extract potency differs between products, as does proliferation-inhibition potency, again citing quantitative and qualitative variations in the active ingredient as likely reasons for these differences.
The investigators found no significant difference between the SPE and placebo groups in change in American Urological Association Symptom Index scores, maximal urinary flow rate, prostate size, residual volume after voiding, quality of life, or serum prostate-specific antigen levels during the study.
An earlier publication by our group reported the results of an in vitro study of an SPE made using ethanol as the solvent. This procedure was repeated twice. Provided as oily extract, SPSE was diluted to working solutions of fivefold-higher strength than the intended test dilutions: Since the stock solution was insoluble in sodium citrate assay buffer, dilutions of the extract were prepared as follows.
The stock solution was diluted in phosphate-buffered saline PBS , and NaOH was then added until the test item was dissolved pH in the range, Prior to application, aliquots of test item starting solutions were diluted with sodium citrate buffer at a pH of 5. The final solvent concentrations were 0.
Serving as an internal control, finasteride was dissolved in ethanol, further diluted in PBS, and tested at a final concentration of 6 nM.
Solvent-treated controls were processed similarly, and contained 0. The addition of cellular homogenates started the enzyme reactions. Autotuning was carried out for maximizing ion abundance, followed by the identification of characteristic fragment ions using a generic parameter set parameters will be listed.
Ions with the highest signal-to-noise ratios were used to quantify the item in the selected reaction-monitoring mode and as qualifier, respectively.
The gradients presented in Table 1 were used to detect the test items. Mass spectrometry and chromatographic parameters are presented in Table 2.
HPLC, high-performance liquid chromatography. Results are displayed as peak area ratio, in which the area of the analyte peak is divided by the area of the internal standard peak. Conversion rates were calculated according to the following formula:. The assay setup included a positive-control inhibitor.
The following final concentrations of SPSE were tested: The IC 50 value was calculated to be 3. Competitive binding of the test items toward the active site of the enzyme can be assumed, based on the resulting concentration—response curve. Figure 1 displays the results obtained from the cell-free IC 50 -determination experiment. IC 50 , half-maximal inhibitory concentration; SEM, standard error of mean. Figure 2 presents the dose—response curve for finasteride obtained with the cell homogenate that was used for the assays.
Testing took place in a cell-free assay, and used cell homogenates that had been isolated from stably transfected HEK cells. The IC 50 for this extract was determined to be 3. SP, moreover, exerts anti-inflammatory effects that may also have salubrious effects on prostate health. The bioactive compounds contained in hexane and diethyl ether extracts of SP were isolated and characterized by Abe et al.
With IC 50 values of 3. As reported by study participants, sexual function remained stable for the first year of treatment and significantly improved during the second year. After receiving placebo for 1 month, men aged 45 years or older with moderate-to-severe symptoms of BPH were randomly assigned in another study to receive either SP or placebo for an additional 6 months. The investigators concluded that SP significantly improved urinary symptoms compared to placebo.
Suter et al conducted an open clinical pilot trial to investigate whether an SP berry preparation influenced BPH symptoms and sexual dysfunction.
Correlation analyses confirmed the relationship between improved BPH symptoms and reduced sexual dysfunction. The investigators found that SPE showed no evidence of toxicity at doses up to three times the usual clinical dose over a period of 18 months.
The strongest evidence for the competitive efficacy and tolerability of SP in the treatment of BPH comes from randomized studies. Either alone or in combination with other plant extracts, SPE appears to be a viable option for improving lower urinary tract symptoms and flow measures. Although the evidence is less strong for Hypoxis rooperi and Secale cereale , these extracts also appear to improve symptoms of BPH.
In a recent review of the literature, Minutoli et al concluded that SP may have greater potential for the management of BPH when combined with selenium and lycopene. The investigators in that study reported SPE and tamsulosin to be effective alone, but that no treatment demonstrated superiority, and combined therapy provided no further benefit.
The investigators concluded that SPE is well tolerated and can be effective in the treatment of urinary tract symptoms secondary to BPH. Such inconsistent results may partly be the result of the varying bioactivities of the extracts used in those trials. Further evaluations of standardized preparations of phytotherapeutic agents in randomized controlled trials with longer study durations will help in determining the long-term effectiveness of these products in the treatment of BPH.
The strengths of this study lie in its well-validated scientific methods and the robust data generated, particularly the striking IC 50 found for SPSE and its ability to reduce DHT, the main factor leading to prostate growth.
Areas for future investigation, however, could include direct comparisons to competitor products, such as other CO 2 or ethanolic extracts. The comparative differences among these extracts might also be further elucidated through analytical comparisons, such as those conducted by Booker et al, who characterized 57 different SP products using two distinct analytical approaches and found a high level of heterogeneity among the nine fatty acids contained in the various products.
Not only does SPSE effectively inhibit the enzyme that has been linked to BPH, but the amount of extract required for activity is also very low compared to data for other extracts that have been reported in similar tests.
By establishing the bioactivity of SPSE, the present study reinforces the importance of conducting such trials prior to attempting clinical studies. Confirming bioactivity increases the likelihood of showing positive effects clinically, while reducing the chances of negative studies, such as those reported in the literature.
Future in vitro and clinical trials involving SPEs would be useful for elucidating their comparative differences as well as appropriate patient selection for their use. This study was sponsored by Euromed, Barcelona, Spain. The authors thank Pharmacelsus, Saarbrücken, Germany for their contributions to the design and conduct of this study, as well as for data analyses and data reporting.
The authors also thank Aesculapius Consulting, Inc. Support for this assistance was provided by Euromed. This study was funded by Euromed, Barcelona, Spain. The authors report no other conflicts of interest in this work. All authors contributed toward data analysis, drafting and critically revising the paper and agree to be accountable for all aspects of the work.
National Center for Biotechnology Information , U. Journal List Res Rep Urol v. Published online Apr This work is published and licensed by Dove Medical Press Limited.
The full terms of this license are available at https: By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
Conclusion SPSE effectively inhibits the enzyme that has been linked to BPH, and the amount of extract required for activity is comparatively low.
Assays of cell-free in vitro inhibition Provided as oily extract, SPSE was diluted to working solutions of fivefold-higher strength than the intended test dilutions: Table 1 HPLC gradients test and reference items. Open in a separate window. Table 2 Mass spectrometry and chromatographic parameters test and reference items. Data analysis Results are displayed as peak area ratio, in which the area of the analyte peak is divided by the area of the internal standard peak. Conversion rates were calculated according to the following formula: Quality control Assay acceptability The assay setup included a positive-control inhibitor.
Nonclinical trials with saw palmetto The bioactive compounds contained in hexane and diethyl ether extracts of SP were isolated and characterized by Abe et al.
Acknowledgments This study was sponsored by Euromed, Barcelona, Spain.
Aufbauende androgene Steroide
ON DIHYDROTESTOSTERONE - Deutsch Übersetzung - Englisch Beispiele | Reverso Context
Relation between patient age and dihydrotestosterone formation by slices of hormone to a 1oca 11y active derivative with Dihydrotestosterone Formation in. Sept. DHEA. Androstenedione. Dihydrotestosterone DHT ist für einige Nebenwirkungen verantwortlich . Stickstoff enthaltene Steroidderivative. Übersetzung für "ON DIHYDROTESTOSTERONE" im Deutsch and 7, wherein said androgen or androgen analogue is a 4,5a-dihydrotestosterone derivative.